Invention Grant
- Patent Title: Compounds for treatment of cancer
-
Application No.: US17370201Application Date: 2021-07-08
-
Publication No.: US12187720B2Publication Date: 2025-01-07
- Inventor: Wei Li , Duane D Miller , Kinsie E. Arnst , Dong-Jin Hwang
- Applicant: ONCTERNAL THERAPEUTICS, INC. , UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- Applicant Address: US CA San Diego; US TN Knoxville
- Assignee: ONCTERNAL THERAPEUTICS, INC.,UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- Current Assignee: ONCTERNAL THERAPEUTICS, INC.,UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- Current Assignee Address: US CA San Diego; US TN Knoxville
- Agency: PEARL COHEN ZEDEK LATZER BARATZ LLP
- Agent Mark S. Cohen
- Main IPC: C07D417/14
- IPC: C07D417/14 ; A61P35/00 ; C07C49/786 ; C07D211/14 ; C07D213/76 ; C07D217/04 ; C07D233/64 ; C07D277/24 ; C07D405/06 ; C07D417/04 ; C07D417/12
Abstract:
The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.
Public/Granted literature
- US20220024912A1 COMPOUNDS FOR TREATMENT OF CANCER Public/Granted day:2022-01-27
Information query
